
PP120. COMPOUND HETEROZYGOSITY FOR HEMOGLOBIN KNOSSOS AND IVS-I-6 MUTATION IN A MACEDONIAN BOY STANOJEVIC E.1, Glamocanin S.2, Plaseska-Karanfilska D.1, Efremov G.D.1
1Macedonian Academy of Science and Arts, Research Center for Genetic Engineering and Biotehnology Skopje, Republic of Macedonia; 2 Pediatric Clinic, Faculty of Medicine, Skopje, Republic of Macedonia
*Corresponding Author: page: 102
|
Abstract
Since the first description of hemoglobin Knossos (Hb b27 Ala®Ser) in a Greek family in 1982, as a silent b+ thalassemia variant, this Hb variant has been observed in other families of Mediterranean origin (Turkey, Egypt, Algeria, Cyprus). It has been found in combination with other b thalassemia mutations: Cd 8, IVS-I-1, IVS-I-6 and IVS-I-110, as well as in combination with Hb S and Hb Lepore. We have observed this Hb variant in association with codon 39 mutation in a Bulgarian patient in 1988. Here, we present the first Macedonian patient with thalassemia intermedia due to compound heterozygosity for Hb Knossos and IVS-I-6 mutation. The proband was a 8-months-old boy, when studied for the first time. He was reffered because of microcytic hypochromic anemia. The hematological analysis of the proband revealed Hb 7.0g/dl; PCV 0.23 l/l; RBC 4.3´1012/l; MCV 54 fl; MCH 16.3 pg. No abnormal Hb was detected by starch gel electrophoresis. Routine DNA analysis (ASO hybridization for the most common mutations) revealed IVS-I-6 mutation in the proband and his father. Since the anemia persisted, the patient was reffered to us again at the age of five years. His hematological and hemoglobin analysis showed: Hb 7.6g/dl; PCV 0.26 l/l; RBC 4.8´1012/l; MCV 54 fl; MCH 16.0 pg. Osmotic fragility was positive, n-butanol test for stability was negative; HbA2 3.9%; HbF 4.2%. An abnormal band, migrated between a and b chains, was detected by electrophoresis in 6M urea and Triton X-100 in the propositus and his mother. Direct DNA sequencing revealed that the propositus is compound heterozygous for Hb Knossos (Codon 27 GCC ®TCC) and IVS-I-6 mutation (T->C), while his mother is a carrier of Hb Knossos.
Key words: Hb Knossos, IVS-I-6, b thalassemia intermedia.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|